{
    "code": "52026674",
    "url": "http:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=52026674",
    "time": "2016-01-22 04:07:35",
    "許可證字號": "衛部藥輸字第026674號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "109\/12\/03",
    "發證日期": "104\/12\/03",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA05202667403",
    "中文品名": "立克癌 膠囊 150 毫克",
    "英文品名": "Zykadia capsules 150 mg",
    "適應症": "ZYKADIA適用於在crizotinib治療中惡化或無法耐受之ALK陽性的晚期非小細胞肺癌患者。",
    "劑型": "130膠囊劑",
    "包裝": "10-1000粒鋁箔盒裝",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "主成分略述": "Ceritinib",
    "限制項目": [
        "02輸入",
        "1EPhaseIVStudy",
        "51免除銜接性臨床試驗"
    ],
    "申請商名稱": "1422701100  台灣諾華股份有限公司",
    "申請商地址": "台北市中正區仁愛路二段99號11、12、13樓",
    "主製造廠": {
        "製造廠名稱": "F430088000  NOVARTIS PHARMA STEIN AG",
        "製造廠廠址": "SCHAFFHAUSERSTRASSE CH-4332 STEIN, SWITZERLAND",
        "製造廠公司地址": "CH-4002,BASEL,SWITZERLAND",
        "製造廠國別": "SWITZERLAND",
        "製程": ""
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1013005200",
            "成分名稱": "Ceritinib",
            "含量描述": "",
            "含量": "150.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "020266740004-105-01-19.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026674&Seq=001&Type=9"
        },
        {
            "title": "020266740003-105-01-19.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026674&Seq=003&Type=8"
        },
        {
            "title": "020266740002-105-01-19.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026674&Seq=002&Type=8"
        },
        {
            "title": "020266740001-105-01-19.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026674&Seq=001&Type=8"
        }
    ]
}